Literature DB >> 2651850

Drug-induced priapism. Its aetiology, incidence and treatment.

J E Baños1, F Bosch, M Farré.   

Abstract

Priapism is characterised by a persistent erection that cannot be relieved by sexual intercourse or masturbation. Although priapism subsides spontaneously in a few days, impotence frequently follows. Both vascular and neural mechanisms are implicated in the pathophysiology of priapism, but it is not clear which initiates the process. Idiopathic cases of priapism are the most frequent (near 50%); other medical conditions that can result in priapism are haematological diseases (mainly sickle cell anaemia and leukaemia), traumatism, and neoplastic processes. Drug-induced priapism comprises about 30% of cases. The drugs most frequently implicated are psychotropic drugs (phenothiazines and trazodone), antihypertensives (mainly prazosin) and heparin. Recently, the intracavernosal injection of vasoactive drugs (papaverine and phentolamine) has been described in patients treated for impotence. With the exception of heparin, an alpha-adrenergic blocking mechanism has been suggested in the priapism-inducing action of these drugs. A significant number of anecdotal case reports link priapism and drugs, and it is possible that certain cases of idiopathic priapism could be reclassified if accurate pharmacological anamnesis were to be performed. Priapism must be considered a urological emergency. Surgical procedures are the most preferred treatment for this condition but, in selected cases, drug treatment seems to be an alternative approach.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651850     DOI: 10.1007/bf03259902

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  156 in total

1.  Experiences with priapism.

Authors:  P J Moloney; G B Elliott; H W Johnson
Journal:  J Urol       Date:  1975-07       Impact factor: 7.450

2.  Treatment of priapism: comparison of methods in fifteen cases.

Authors:  J F FARRER; W E GOODWIN
Journal:  J Urol       Date:  1961-12       Impact factor: 7.450

3.  Priapism: an unusual presentation.

Authors:  R S Hillis; W L Weems
Journal:  J Urol       Date:  1976-07       Impact factor: 7.450

4.  [Priapisms during neuroleptic drug administration (3 cases)].

Authors:  M Bourgeois
Journal:  Nouv Presse Med       Date:  1972-04-22

5.  Priapism treated with benztropine.

Authors:  W M Greenberg; K K Lee
Journal:  Am J Psychiatry       Date:  1987-03       Impact factor: 18.112

6.  [Priapism through the centuries].

Authors:  C Jolidon; M Cordier; Y Lanson
Journal:  J Urol (Paris)       Date:  1985

7.  [Current pathogenetic and therapeutic concepts concerning priapism].

Authors:  V Saba; G Muzzonigro; F Mingolla; F Aló
Journal:  Minerva Med       Date:  1980-01-28       Impact factor: 4.806

8.  Priapism with trazodone (Desyrel).

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1984-03-30       Impact factor: 1.909

9.  Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide.

Authors:  P O Andersson; S R Bloom; S Mellander
Journal:  J Physiol       Date:  1984-05       Impact factor: 5.182

10.  Priapism: etiology, treatment, and results in series of 35 presentations.

Authors:  R A Bertram; G D Webster; C C Carson
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

View more
  6 in total

1.  Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism.

Authors:  P A Routledge; H G Shetty; J P White; P Collins
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

2.  Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.

Authors:  Ramiro Juncos; Luis Juncos; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  J Cardiovasc Pharmacol       Date:  2011-02       Impact factor: 3.105

Review 3.  Review of Ischemic and Non-ischemic Priapism.

Authors:  Mark G Biebel; Martin S Gross; Ricardo Munarriz
Journal:  Curr Urol Rep       Date:  2022-05-10       Impact factor: 3.092

4.  The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections.

Authors:  R G Serrate; J Prats; R Regué; G Rius
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Priapism and renal colic in a patient treated with duloxetine.

Authors:  G Lucy Wilkening; Shelly A Kucherer; Antoine B Douaihy
Journal:  Ment Health Clin       Date:  2016-06-29

6.  Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria.

Authors:  Mulugeta Russom; Yodit Fitsum; Merhawi Debesai; Natnael Russom; Merhawi Bahta
Journal:  Pharmacol Res Perspect       Date:  2022-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.